Allen Ebens
Scientific Advisory Board
Patrys
Australia
Biography
Dr Allen Ebens completed a PhD at UCLA and completed a Post-Doc at UCSF before joining Exelixis as a scientist in the Discovery Biology group. After more than 5 years with Exelixis Dr Ebens moved to Genentech where over 11 years in the Research Oncology group he worked from concept to clinic across multiple therapeutic platforms including antibodies, small molecule drugs, antibody-drug conjugates, and cell-based therapies. Dr Ebens was recruited from Genentech to establish the oncology research lab at Juno Therapeutics, and he is currently the Senior Director, Immune Oncology at NGM Biopharmaceuticals in South San Francisco. Over a significant career Dr Ebens’ contributions include advancement of five discovery projects to clinical development and leadership of T cell recruiting bi-specific antibody teams to proof of concept for multiple targets including one clinical candidate.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management
